Hypochondroplasia Latest Advances

Pathways to Facilitate Early Recognition and Diagnosis of Hypochondroplasia.

Journal: Advances in therapy

Published: December 24, 2025

ACAN-related disorder, antenatal presentation and phenotypic variability: a case series.

Journal: Journal of medical genetics

Published: November 10, 2025

Clinical features and variant spectrum of FGFR3-related disorders

Journal: Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics

Published: October 22, 2025

Response to Letter to the Editor for "Infigratinib low dose therapy is an effective strategy to treat hypochondroplasia".

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: October 08, 2025

The Metacarpophalangeal Pattern Profile: An Old Method With New Insights Into the Evaluation of Short Stature.

Journal: American journal of human biology : the official journal of the Human Biology Council

Published: September 22, 2025

Effect of Vosoritide therapy on IGF-I and Endogenous C-type Natriuretic Peptide in Hypochondroplasia.

Journal: The Journal of clinical endocrinology and metabolism

Published: September 07, 2025

Infigratinib is a weak inhibitor of the FGFR3-N540K mutant associated with hypochondroplasia.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: August 22, 2025

Targeting fibroblast growth factor receptor 3 gain-of-function with Infigratinib, a promising precision therapy for hypochondroplasia.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: August 07, 2025

Prevalence of low birth weight, short length, and body disproportion at birth in patients with skeletal dysplasias: A retrospective study.

Journal: Archivos argentinos de pediatria

Published: July 15, 2025

Acute arterial ischemic stroke in children: single-center experience.

Journal: Arquivos de neuro-psiquiatria

Published: June 25, 2025

Achondroplasia and hypochondroplasia in France: a nationwide epidemiological analysis.

Journal: Orphanet journal of rare diseases

Published: June 23, 2025

The Head Circumference Height Index (HCH-I) to Quantify Relative Macrocephaly and Aid Identification of Hypochondroplasia in Children.

Journal: American journal of medical genetics. Part A

Published: June 14, 2025

Hypochondroplasia Latest Advances

Find the Latest Research About Hypochondroplasia

Pathways to Facilitate Early Recognition and Diagnosis of Hypochondroplasia.

Pathways to Facilitate Early Recognition and Diagnosis of Hypochondroplasia.

ACAN-related disorder, antenatal presentation and phenotypic variability: a case series.

ACAN-related disorder, antenatal presentation and phenotypic variability: a case series.

Clinical features and variant spectrum of FGFR3-related disorders

Clinical features and variant spectrum of FGFR3-related disorders

Response to Letter to the Editor for "Infigratinib low dose therapy is an effective strategy to treat hypochondroplasia".

Response to Letter to the Editor for "Infigratinib low dose therapy is an effective strategy to treat hypochondroplasia".

The Metacarpophalangeal Pattern Profile: An Old Method With New Insights Into the Evaluation of Short Stature.

The Metacarpophalangeal Pattern Profile: An Old Method With New Insights Into the Evaluation of Short Stature.

Effect of Vosoritide therapy on IGF-I and Endogenous C-type Natriuretic Peptide in Hypochondroplasia.

Effect of Vosoritide therapy on IGF-I and Endogenous C-type Natriuretic Peptide in Hypochondroplasia.

Infigratinib is a weak inhibitor of the FGFR3-N540K mutant associated with hypochondroplasia.

Infigratinib is a weak inhibitor of the FGFR3-N540K mutant associated with hypochondroplasia.

Targeting fibroblast growth factor receptor 3 gain-of-function with Infigratinib, a promising precision therapy for hypochondroplasia.

Targeting fibroblast growth factor receptor 3 gain-of-function with Infigratinib, a promising precision therapy for hypochondroplasia.

Prevalence of low birth weight, short length, and body disproportion at birth in patients with skeletal dysplasias: A retrospective study.

Prevalence of low birth weight, short length, and body disproportion at birth in patients with skeletal dysplasias: A retrospective study.

Acute arterial ischemic stroke in children: single-center experience.

Acute arterial ischemic stroke in children: single-center experience.

Achondroplasia and hypochondroplasia in France: a nationwide epidemiological analysis.

Achondroplasia and hypochondroplasia in France: a nationwide epidemiological analysis.

The Head Circumference Height Index (HCH-I) to Quantify Relative Macrocephaly and Aid Identification of Hypochondroplasia in Children.

The Head Circumference Height Index (HCH-I) to Quantify Relative Macrocephaly and Aid Identification of Hypochondroplasia in Children.